Evaluate : Actualité Evaluate en direct - P1 | Bourse Reflex
Accueil > Tags > Evaluate

  • Toutes les actualités en rapport avec « Evaluate »

27/04 07:30 Evaluate - Sequana - First-quater 2018 results

19/04 18:00 Evaluate - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

19/04 17:45 Evaluate - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

10/04 07:30 Evaluate - Full-Year 2017 results

29/03 18:00 Evaluate - Quantum Genomics publishes its financial results for the year 2017

05/03 18:30 Evaluate - Quantum Genomics Secures Operational Flexibility and Growth Capital through Equity Line Financing with Kepler Cheuvreux

15/11 07:30 Evaluate - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States

27/10 07:30 Evaluate - Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study

03/10 18:15 Evaluate - Quantum Genomics Releases 2017 First-Half Financial Results and First Nine Months Business Update

04/07 19:30 Evaluate - OPENING OF THE PUBLIC TENDER OFFER FOR FUTUREN

29/09 17:45 Evaluate - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

28/04 18:35 Evaluate - BUSINESS UPDATE - FIRST QUARTER 2016

16/03 21:30 Evaluate - Legal action filed against Moneta Asset Management

14/03 07:00 Evaluate - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

25/01 18:00 Evaluate - BUSINESS UPDATE - FOURTH QUARTER 2015

07/01 07:30 Evaluate - GENTICEL TO EVALUATE ROCHE MOLECULAR SYSTEMS' COBAS(R) HPV TEST IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

21/09 17:40 Evaluate - Genticel presents first half 2015 financial results, operational progress and outlook

28/07 18:00 Evaluate - Business Update - Second Quarter 2015

07/07 18:00 Evaluate - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

02/07 08:00 Evaluate - Quantum Genomics speeds its development work in the field of heart failure